It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.
According to research, ownership of smartphones and tablets in particular have grown rapidly over the past couple of years, and that has created a multi-headed omnichannel hydra of a customer who retailers across all channels are desperately trying to appease.
With the steady accumulation of purchasing power attributed to the Hispanic-American community, marketers more and more are targeting Latinos. DSN called in Reny Diaz, director of client engagement for Nielsen, for additional perspective about the Hispanic-American opportunity.
The Hispanic opportunity represents a "new American reality," noted Roberto Ruiz, SVP strategy and insights for Univision Communications, last month at the Consumer Healthcare Products Association's Annual Executive Conference.
Hointer, which opened last fall, allows men to buy jeans by combining "online conveniences without the offline B.S." Customers walk in, download an app onto a smartphone or tablet, scan a QR code on the tag and are automatically directed to a dressing room.
DSN spoke at length with two Catamaran executives — Albert Thigpen, SVP pharmacy operations and industry relations, and Sumit Dutta, SVP and chief medical officer — about the PBM’s new approach to managed pharmacy care and the changes driving that strategy.
While the Food and Drug Administration released draft guidance on regulations for biosimilars in February 2012, the final regulations have yet to appear. But already, everyone from analysts to trade groups to drug makers is preparing for a time when knock-off versions of biotech drugs will become available.
Much of the policy-making conversation about health care in recent years has sought to highlight anticipated cost savings from technology innovation. Critics say this is an outgrowth of the American "fix-it" mentality. Others say technical solutions have yet to take hold outside of medical accounting applications. But there is general agreement that in the area of technologies to nurture medication adherence, the ground remains fertile.